top of page
Home
About Us
Team
Science
Pipelines
Ulcerative Colitis
Atopic Dermatitis
COVID-19
Diabetes
Nonalcoholic fatty liver disease
Gout
Investor Relations
Contact
More
Use tab to navigate through the menu items.
Investor Relations
SEC Filings
Investor Relations
NEWS / EVENTS
Press Release
Events & Presentations
SEC FILINGS
STOCK INFO
GOVERNANCE
Governance Documents
8/26/25
424B4
Prospectus filed pursuant to Rule 424(b)(4)
html
8/26/25
8-K
Current report
html
8/25/25
CERT
CERT
html
8/25/25
8-A12B
8-A12B
html
8/12/25
EFFECT
EFFECT
html
8/8/25
CORRESP
CORRESP
html
8/8/25
CORRESP
CORRESP
html
7/22/25
FWP
FWP
html
7/18/25
S-1/A
Securities Registration: General - amendment
html
7/10/25
FWP
FWP
html
2
3
4
5
6
1
...
1
2
3
4
5
6
7
...
7
bottom of page